Cerebral vasospasm following subarachnoid hemorrhage: Time for a new world of thought

Neurological Research

Volumn 31, Issue 2, 2009, Pages 151-158

  Zhang, John H ^a   Pluta, Ryszard M ^b   Hansen Schwartz, Jacob ^b   Dreier, Jens ^b   Vajkoczy, Peter ^b   Macdonald, R Loch ^b   Nishizawa, Shigeru ^b   Kasuya, Hideotoshi ^b   Wellman, George ^b   Keller, Emanuela ^b   Zauner, Alois ^b   Dorsch, Nicholas ^b   Clark, Joseph ^b   Ono, Shigeki ^b   Kiris, Talat ^b   Leroux, Peter ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b NONE

Author keywords

Early brain injury; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

CLAZOSENTAN; ENDOTHELIN 1; ENOXAPARIN; FASUDIL; GLYCERYL TRINITRATE; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM SULFATE; NICARDIPINE; NIMODIPINE; NITRIC OXIDE; PAPAVERINE; PRAVASTATIN; SIMVASTATIN; UROKINASE; VERAPAMIL;

ARTERY OCCLUSION; ASIA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL TRIAL; DRUG RELEASE; EUROPE; HUMAN; MOLECULAR DYNAMICS; MORBIDITY; MORTALITY; NEUROPATHOLOGY; NONHUMAN; NORTH AMERICA; PATHOPHYSIOLOGY; REVIEW; SPREADING CORTICAL DEPRESSION; SUBARACHNOID HEMORRHAGE; SURGICAL DRAINAGE;

ANIMALS; CEREBRAL CORTEX; HUMANS; INTERNATIONAL COOPERATION; SPREADING CORTICAL DEPRESSION; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 62549125030     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X393564     Document Type: Review

References (76)

1. Clarke E. Apoplexy in the Hippocratic writings. Bull Hist Med 1963; 37: 301
2. Burnett M, Danish S, McKhann G II, et al. Pathology and pathophysiology of aneurysmal subarachnoid hemorrhage. In: Leroux P, Winn W, Newell D, eds. Management of Cerebral Aneurysms, Philadelphia, PA: Elsevier, 2004: pp. 127-137
3. Weir B, Grace M, Hansen J, et al. Time course of vasospasm in man. J Neurosurg 1978; 48: 173-178
4. Kassell N, Torner J, Haley E, Jr. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990; 73: 18-36
5. Dorsch N. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care, 2002; 8: 128-133
6. Ecker A, Rimenschneider P. Arteriographic demonstration of spasm of the intracranial arteries with special reference to saccular arterial aneurysms. J Neurosurg 1951; 8: 660-667
7. Vajkoczy P, Meyer B, Weidauer S, et al. Clazosentan (AXV034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: Results of a randomized, double-blind, placebo-controlled, multicenter phase Ila study. J Neurosurg 2005; 103: 9-17
8. Nornes H. The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysms. J Neurosurg 1973; 39: 226-234
9. Grant G, Janigro D, Winn H. Subarachnoid hemorrhage and the blood-brain barrier. In: Leroux P, Winn W, Newell D, eds. Management of Cerebral Aneurysms, Philadelphia, PA: Elsevier, 2004: pp. 121c137
10. Trojanowski T. Blood Elsevier brain barrier changes after experimental subarachnoid hemorrhage. Acta Neurochir (Wien) 1982; 60: 45-54
11. Baldwin ME, Macdonald R, Huo D, et al. Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 2004; 35: 2506-2511
12. Dreier J, Ebert N, Priller J, et al. Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: A model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg 2000; 93: 658-666
13. Ostrowski RP, Colohan AR, Zhang JH. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 2006; 28 (4): 399-414
14. Cahill WJ, Calvert JH, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006; 26: 1341-1353
15. Pluta R. Delayed cerebral vasospasm and nitric oxide: Review, new hypothesis, and proposed treatment. Pharmacol Ther 2005; 105: 23-56
16. SeifertV,LofflerB,Zimmermann M, et al. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage: Correlation with cerebral vasospasm, delayed ischemic neurological deficits and volume of hematoma. J Neurosurg 1995; 82: 55-62
17. Sehba F, Bederson J. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res 2006; 28: 381-398
18. + channel activator cromakalim.Sfroke 1996; 27: 311-316
19. Turner C, Bergeron M, Matz P, et al. Heme oxygenase-1 is induced in glia throughout brain by subarachnoid hemoglobin. J Cereb Blood Flow Metab 1998; 18: 257-273
20. Vikman P, Beg S, Khurana T, et al. Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat. J Neurosurg 2006; 105: 438-444
21. Dietrich H, Dacey R. Molecular keys to the problems of cerebral vasospasm. Neurosurgery 2000; 46: 517-530
22. Clark JF, Sharp FR. Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006; 26 (10): 1223-1233
23. Nishizawa S, Laher I. Signaling mechanisms in cerebral vasospasm. Trends Cardiovasc Med 2005; 15 (1): 24-34
24. Ohkuma H, Tsurutani H, Suzuki S. Changes of beta-actin mRNA expression in canine vasospastic basilar artery after experimental subarachnoid hemorrhage. Neurosci Lett 2001; 311 (1): 9-12
25. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415
26. Pluta R, Boock R, Afshar J, et al. The source and cause of endothelin 1 release to CSF after SAH. J Neurosurg 1997; 87: 287-293
27. Zimmermann M, Seifert V, Endothelin and subarachnoid hemorrhage: An overview. Neurosurgery 1998; 43: 863-875
28. Kasuya H, Weir B, White D, et al. Mechanism of oxyhemoglobin- induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J Neurosurg 1993; 79: 892-898
29. Fassbender K, Hodapp B, Rossol S, et al. Endothelin-1 in subarachnoid hemorrhage: An acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 2000; 31: 2971-2975
30. Alabadi JA, Salom J, Torregrosa G, et al. Changes in the cerebrovascular effects of endothelin-1 and nicardipine after experimental subarachnoid hemorrhage. Neurosurgery 1993; 33: 707-714
31. Macdonald, RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: The emerging revolution. Nat Clin Pract Neurol 2007; 3 (5): 256-263
32. Luders J, Weihl C, Lin G, et al. Adenoviral gene transfer of nitric oxide synthase increases cerebral blood flow in rats. Neurosurgery 2000; 47: 1206-1214
33. Smith RS, Jr, Agata J, Xia CF, et al. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci 2005; 76 (21): 2457-2471
34. Pluta R, Oldfield E, Boock R. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 1997; 87: 746-751
35. Thomas J, Rosenwasser R. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: Initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery 1999; 44 (1): 48-57
36. Clatterbuck RE, Gailloud P, Tierney T, et al. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg 2005; 103: 745-751
37. Tierney T, Pradilla G, Wang P, et al. Intracranial delivery of the nitric oxide donor diethylenetriamine/nitric oxide from a con- trolled-release polymer: Toxicity in cynomolgus monkeys. Neurosurgery 2006; 58: 952-960
38. Pluta RM, Dejam A, Grimes G, et al. Nitrite infusions prevent cerebral artery vasospasm in a primate model of subarachnoid aneurysmal hemorrhage. JAMA 2005; 293: 1477-1484
39. Khurana V, Sohni Y, Mangrum W, et al. Endothelial nitric oxide synthase gene polymorphism predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm. J Cereb Blood Flow Metab 2004; 24: 291-297
40. McGirt MJ, Lynch J, Parra A, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002; 33: 2950-2956
41. Endres M, Laufs U. [HMG-CoA reductase inhibitor and risk of stroke]. Nervenarzt 1998; 69 (8): 717-721 [in German]
42. Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998; 273 (37): 24266-24271
43. McGirt M, Pradilla G, Legnani F, et al. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 2006; 58: 945-951
44. Lynch J, Wang H, McGirt M, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: Results of a pilot randomized clinical trial. Stroke 2005; 36: 2024-2026
45. Tseng M-Y, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 2005; 36: 1627-1632
46. Paulson OB, Newman EA. Does the release of potassium from astrocyte endfeet regulate cerebral blood flow? Science 1987; 237 (4817): 896-898
47. Kassell N, Sasaki T, Colohan A, et al. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16: 562-572
48. Jakobsen M, Enevoldsen E, Dalager T. Spasm index in subar- achnoid hemorrhage: Consequences of vasospasm upon cerebral blood flow and oxygen extraction. Acta Neurol Scand 1990; 82 (5): 311-320
49. Ohkuma H, Manabe H, Tanaka M, et al. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000; 31 (7): 1621-1627
50. Shimoda M, Takeuchi M, Tominago J, et al. Asymptomatic versus symptomatic infarct from vasospasm in patients with subarachnoid hemorrhage: Serial magnetic resonans imaging. Neurosurgery 2001; 49: 1341-1348
51. Treggiari-Venzi M, Suter P, Romand J-A. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: A problem of neurointensive care. Neurosurgery 2001; 48: 249-262
52. 2+ sparks and their function in human cerebral arteries. Stroke 2002; 33 (3): 802-808
53. 2+-activated potassium channels and ATP-sensitive potassium channels as modulators of vascular tone. Trends Cardiovasc 1993; 3: 54-60
54. Wellman T, Jenkins J, Penar P, et al. Nitric oxide and reactive oxygen species exert opposing effects on the stability of hypoxia-inducible factor-1alpha (HIF-1alpha) in explants of human pial arteries. FASEB J 2004; 18: 379-381
55. 2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage. Circ Res 2005; 96 (4): 419-426
56. Harder D, Dernbach P, Waters A. Possible cellular mechanism for cerebral vasospasm after subarachnoid hemorrhage in the dog. J Clin Invest 1987; 80: 875-880
57. ++ sparks by oxyhemoglobin in rabbit cerebral arteries. J Neurosurg 2004; 100 (2): 295-302
58. Roman RJ, Renic M, Dunn KM, et al. Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm. Neurol Res 2006; 28 (7): 738-749
59. Kusaka G, Ishikawa M, Nanda A, et al. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004; 24: 916-925
60. Park S, Yamaguchi M, Zhou C, et al. Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 2004; 35: 2412-2417
61. Claassen J, Carhuapoma J, Kreiter K, et al. Global cerebral edema after subarachnoid hemorrhage: Frequency, predictors, and impact on outcome. Stroke 2002; 33: 1225-1232
62. + is increased in the subarachnoid space. J Cereb Blood Flow Metab 1998; 18 (9): 978-990
63. Birse SH, Tom MI. Incidence of cerebral infarction associated with ruptured intracranial aneurysms. A study of 8 unoperated cases of anterior cerebral aneurysm. Neurology 1960; 10: 101-106
64. Neil-Dwyer G, Lang D, Doshi B, et al. Delayed cerebral ischaemia: The pathological substrate. Acta Neurochir (Wien) 1994; 131: 137-145
65. Dreier JP, Woitzik J, Fabricius M, et al. Delayed is chaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006; 129 (Pt 12): 3224-32237
66. Shin H, Dunn A, Jones P, et al. Vasoconstrictive neurovascular coupling during focal ischemic depolarizations. J Cereb Blood Flow Metab 2006; 26: 1018-1030
67. Andaluz N, Zuccarello M. Fenestration of the lamina terminalis as a valuable adjunct in aneurysm surgery. Neurosurgery 2004; 55 (5): 1050-1059
68. Kiriş T, Erden T, Sahinbas M, et al. CSF drainage for prevention and reversal of cerebral vasospasm after surgical treatment of intracranial aneurysms. In: Macdonald RL, ed. Cerebral Vasospasm, New York: Thieme Verlag, 2005: pp. 255-258
69. Klimo P, KestleJ, MacDonaldJ, et al. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 2004; 100: 215-224
70. Yamamoto Y, Ikegaki I, Sasaki Y, et al. The protein kinase inhibitor fasudil protects against ischemic myocardial injury induced by endothelin-1 in the rabbit. J Cardiovasc Pharmacol 2000; 35 (2): 203-211
71. Sayama CM, Liu JK, Couldwell WT. Update on endovascular therapies for cerebral vasospasm induced by aneurysmal subar- achnoid hemorrhage. Neurosurg Focus 2006; 21 (3): E12
72. Kasuya H, Onda H, Takeshita M, et al. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 2002; 33: 1011-1015
73. Kasuya H, Onda H, Sasahara A, et al. Application of nicardipine prolonged-release implants: Analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005; 56 (5): 895-902
74. Hoh BL, Ogilvy CS. Endovascular treatment of cerebral vasospasm: Transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg Clin N Am 2005; 16 (3): 501-516
75. Dirnagl U. Bench to bedside: The quest for quality in experimental stroke research. J Cereb Blood Flow Metab 2006; 26: 1465-1478
76. Ohta T. Cerebral vasospasm revisited: SAH syndrome. In: Macdonald RL, ed. Cerebral Vasospasm: Advances in Research and Treatment, New York: Thieme, 2004: pp. 106-111